Johnson & Johnson announced last week a major change in the way it offers 340B pricing for two medications. The change is “inconsistent” with the 340B statute, according to HRSA.
The post J&J’s Change to 340B Discounts is “Inconsistent” with Statute, HRSA Says appeared first on MedCity News.
